Stocks and InvestingStocks and Investing
Tue, May 25, 2021
Mon, May 24, 2021
Fri, May 21, 2021
Thu, May 20, 2021
Wed, May 19, 2021

Geoff Meacham Maintained (ABBV) at Hold with Increased Target to $113 on, May 19th, 2021


Published on 2024-10-27 16:43:33 - WOPRAI, Geoff Meacham
  Print publication without navigation


Geoff Meacham of B of A Securities, Maintained "AbbVie Inc." (ABBV) at Hold with Increased Target from $110 to $113 on, May 19th, 2021.

Geoff has made no other calls on ABBV in the last 4 months.



There are 9 other peers that have a rating on ABBV. Out of the 9 peers that are also analyzing ABBV, 0 agree with Geoff's Rating of Hold.



These are the ratings of the 9 analyists that currently disagree with Geoff


  • Navin Jacob of "UBS" Maintained at Strong Buy with Increased Target to $126 on, Wednesday, May 12th, 2021
  • Tim Anderson of "Wolfe Research" Maintained at Buy with Increased Target to $127 on, Monday, May 3rd, 2021
  • Vamil Divan of "Mizuho" Maintained at Strong Buy with Increased Target to $128 on, Monday, May 3rd, 2021
  • Daniel Busby of "RBC Capital" Reiterated at Buy and Held Target at $135 on, Monday, May 3rd, 2021
  • Gary Nachman of "BMO Capital" Maintained at Buy with Increased Target to $129 on, Monday, May 3rd, 2021
  • Geoffrey Porges of "SVB Leerink" Maintained at Buy with Increased Target to $144 on, Tuesday, March 30th, 2021
  • Andrew Baum of "Citigroup" Maintained at Strong Buy with Increased Target to $125 on, Friday, March 12th, 2021
  • Randall Stanicky of "RBC Capital" Maintained at Buy with Increased Target to $135 on, Thursday, February 4th, 2021
  • David Risinger of "Morgan Stanley" Maintained at Buy with Decreased Target to $116 on, Thursday, January 28th, 2021